Full Length Research Paper
References
|
Al-Habbal MJ, Al-Habbal Z, Huwez FU (1984). A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. J. Clin. Exp. Pharmacol. Physiol. 11:541-544. Crossref |
||||
| Bland JS (1986). Foreward. In: Mowrey DB (ed.) The Scientific, Validation of Herbal Medicine. Connecticut: Keats Publishing, Inc. ISBN 0-87983-534-536. | ||||
|
Calzada F (2005). Additional antiprotozoal constituents from Cuphea pinetorum, a plant used in Mayan tradi¬tional medicine to treat diarrhea. Phytother. Res. 19:725-727. Crossref |
||||
|
Crawford P (2009). Effectiveness of Cinnamon for Lowering Hemoglobin A1C in Patients with Type 2 Diabetes: A Randomized, Controlled Trial. J. Am. Board. Fam. Med. 22(5):507-512. Crossref |
||||
| Dans L, Martnez L (2007). Amoebic dysentery. Clin. Evid. 1:918-26. | ||||
|
Ernst E (1998) Harmless herbs? A review of the recent, literature. Am. J. Med. 104:170-178. Crossref |
||||
|
Gonzales MLM, Dans LF, Martinez EG (2009). Antiamoebic drugs for treating amoebic colitis. The Cochrane Collaboration, John Wiley & Sons. pp. 1-133. Crossref |
||||
| Gupta YK, Gupta M, Aneja S, Kohli K (2004). Current Drug Therapy of Protozoal Diarrhea Indian. J. Pediatr. 71(1):55-58. | ||||
|
Haque R, Mondal D, Duggal P, Kabir M, Roy S, Farr BM, Sack RB, Petri WA Jr (2006). Entamoeba histolytica infection in children and protection from subsequent amoebiasis. Infect. Immun. 74(2):904-909. Crossref |
||||
|
Herbinger KH, Fleischmann E, Weber C, Perona P, Löscher T, Bretzel G (2011). Epidemiological, clinical and diagnostic data on intestinal infection with Entamoeba histolytica and Entamoeba dispar among returning travellers. Infections 39(6):527-35. Crossref |
||||
|
Huston CD, Boettner DR, Miller-Sims V, Petri WA Jr (2003). Apoptotic killing and phagocytosis of host cells by the parasite Entamoeba histolytica. Infect. Immun. 71(2):964-972. Crossref |
||||
| Iliyas M, Khan IA, Malik GQ, Hansotia MF, Thaver IH, Inam SNB (2006). Public Health and Community Medicine. 7th ed. Karachi: Time publisher. pp. 91-102. | ||||
|
Khairnar K, Parija SC, Palaniappan R (2007). Diagnosis of intestinal amoebiasis by using nested polymerase chain reaction-restriction fragment length polymorphism assay. J. Gastroenterol. 42:631-640. Crossref |
||||
| Khan U, Shahabuddin, Halima N, Hannan A (2008). Unani Herbal Medicine for the Treatment of Amoebiasis. Health Sci. Res. Eastern Med. 1:82-92. | ||||
| Lwanga SK, Lemeshow S (1991). Sample size determination in health studies: A Practical manual. World Health Organization Geneva. pp. 38-39. | ||||
| Mohiuddin E (2007). Comparison of Herbal and Allopathic Medicine for the Treatment of Acute Tonsillitis and Pharyngitis. PhD thesis. Hamdard University. Karachi | ||||
|
Mondal D, Petri Jr WA, Sack RB (2006). Entamoeba histolytica-associated diahorreal illness is negatively associated with the growth of preschool children: evidence from a prospective study. Trans. R. Soc. Trop. Med. H. 11:1032-38. Crossref |
||||
|
Orozco E, López C, Gómez C, Pérez DG, Marchat L, Ba-uelos C, Delgadillo DM (2002). Multidrug resistance in the protozoan parasite Entamoeba histolytica. Parasitol. Int. 51:353-359. Crossref |
||||
| Ozcan M (2004). Characteristics of fruit and oil of terbinthus (Pistacia terbinthus L.) growing wild in Turkey. J. Sci. Food Agric. 84:517-520. Powell SJ (1969). Drug trials in amoebiasis. Bull. World Health Organ. 40(6):956-8. | ||||
|
Ranque S, Molet B, Christmann D, Candolfi E (2004). In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica. Eur. J. Clin. Microbiol. Infect. Dis. 23:932-933. Crossref |
||||
| Shahab-ud-din, Khan U, Sarwar MS, Ejaz M (2006). Clinical Evaluation of some herbal medicine for amoebiasis. Pak. J. Pharmacol. 23(2):9-11. | ||||
|
Siddiqui MI, Bilqees FM, Iliyas M, Perveen S (2002). Prevalence of parasitic infections in a rural area of Karachi, Pakistan. J. Pak. Med. Assoc. 52(7):315-20. Pubmed |
||||
| Siddiqui MI, Usmanghani K, (2012) Comparison of how well allopathic and herbal medicine work for the treatment of Entamoeba histolytica. ISRTCN registry. | ||||
| Tasanor O, Brem B, Leitsch D, Binder M, Duchêne M, Greger H, Wernsdorfer WH (2007). Development of a pharmacodynamic screening model with Entamoeba histolytica. Wien Klin Wochenschr. 119(19-20 Suppl 3):88-95. | ||||
|
Taylor JLS, Rabe T, Mcgaw LJ, Jager AK, Staden JV (2001). Towards the scientific validation of traditional medicinal plants. Plant Growth Regul. 34:23-37. Crossref |
||||
| World Health Organization (WHO) (1981). Intestinal protozoan and helminthic infections. WHO Technical Report Series 666:1-150. | ||||
| WHO Expert Committee on Amoebiasis (1969). Amoebiasis. WHO Technical Report Series 421:5-52. | ||||
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
